Show simple item record

dc.contributor.authorHoffmann, Christopher J
dc.contributor.authorSchomaker, Michael
dc.contributor.authorFox, Matthew P
dc.contributor.authorMutevedzi, Portia
dc.contributor.authorGiddy, Janet
dc.contributor.authorProzesky, Hans
dc.contributor.authorWood, Robin
dc.contributor.authorGarone, Daniela B
dc.contributor.authorEgger, Matthias
dc.contributor.authorBoulle, Andrew
dc.date.accessioned2014-11-30T16:10:08Z
dc.date.available2014-11-30T16:10:08Z
dc.date.issued2013-05-01
dc.identifier.citationCD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa. 2013, 63 (1):34-41 J. Acquir. Immune Defic. Syndr.en_GB
dc.identifier.issn1944-7884
dc.identifier.pmid23344547
dc.identifier.doi10.1097/QAI.0b013e318287c1fe
dc.identifier.urihttp://hdl.handle.net/10144/336375
dc.description.abstractIn many resource-limited settings monitoring of combination antiretroviral therapy (cART) is based on the current CD4 count, with limited access to HIV RNA tests or laboratory diagnostics. We examined whether the CD4 count slope over 6 months could provide additional prognostic information.
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen_GB
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)en_GB
dc.subjectHIV/AIDSen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshAdulten_GB
dc.subject.meshAnti-HIV Agentsen_GB
dc.subject.meshAntiretroviral Therapy, Highly Activeen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshPrognosisen_GB
dc.subject.meshProportional Hazards Modelsen_GB
dc.subject.meshRNA, Viralen_GB
dc.subject.meshSouth Africaen_GB
dc.subject.meshYoung Adulten_GB
dc.titleCD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africaen
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. choffmann@jhmi.eduen_GB
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromes (1999)en_GB
refterms.dateFOA2019-03-04T11:37:47Z
html.description.abstractIn many resource-limited settings monitoring of combination antiretroviral therapy (cART) is based on the current CD4 count, with limited access to HIV RNA tests or laboratory diagnostics. We examined whether the CD4 count slope over 6 months could provide additional prognostic information.


Files in this item

Thumbnail
Name:
Hoffman et al-2013-CD4 Count ...
Size:
320.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record